WS016, a novel potassium binder: safety, tolerability and pharmacodynamics in first-in-human phase 1 healthy volunteer study

被引：0
|
作者：
Zhang, Faming [1 ]
Song, Aiyun [1 ]
Fu, Min [1 ]
Zhou, Youcheng [1 ]
Hu, Minglong [1 ]
机构：
[1] Waterstone Pharmaceut Wuhan Co LTD, Wuhan, Peoples R China
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
2341
引用
收藏
页码：I1149 / I1151
页数：3
相关论文
共 50 条
  • [21] A Phase 1/2, First-in-Human, Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Participants with Glanzmann Thrombasthenia
    Sivapalaratnam, Suthesh
    Austin, Steve
    Lorch, Ulrike
    York, Thomas
    Want, Andrew
    Gosnell, Ashley
    Gandhi, Prafull S.
    Ostergaard, Henrik
    Bjornson, Erik
    O'Meara, Tara
    Sorensen, Benny
    Schutgens, Roger E. G.
    Rea, Catherine
    BLOOD, 2023, 142
  • [22] PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY, AND TOLERABILITY OF ACT-539313, A NOVEL SELECTIVE OREXIN-1 RECEPTOR ANTAGONIST, IN A FIRST-IN-HUMAN STUDY.
    Kaufmann, P.
    Kornberger, R.
    Dingemanse, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S72 - S73
  • [23] First-in-human, randomized dose-escalation study of the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of PF-06480605 in healthy subjects
    Banfield, Christopher
    Rudin, Dan
    Bhattacharya, Indranil
    Goteti, Kosalaram
    Li, Gang
    Hassan-Zahraee, Mina
    Brown, Lisa S.
    Hung, Kenneth E.
    Pawlak, Sylvester
    Lepsy, Christopher
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (04) : 812 - 824
  • [24] The first-in-human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the factor XI monoclonal antibody SHR-2004 in healthy subjects
    Ma, Tingting
    Weng, Zuyi
    Cao, Bei
    Dong, Yanli
    Deng, Chanjuan
    Huang, Lei
    Yang, Yuanxun
    Wang, Yuqi
    Shen, Chenxi
    Wang, Lei
    Shen, Kai
    Li, Juan
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (10) : 1075 - 1082
  • [25] First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Factor XI Monoclonal Antibody SHR-2004 in Healthy Subjects
    Ma, Tingting
    Cao, Bei
    Weng, Zuyi
    Dong, Yanli
    An, Shimin
    Huang, Lei
    Yang, Yuanxun
    Geng, Yan
    Lin, Hui
    Wang, Yuqi
    Xie, Pinhao
    Shen, Kai
    Li, Juan
    BLOOD, 2023, 142
  • [26] A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers
    Susanne Johansson
    David P. Rosenbaum
    Mikael Knutsson
    Maria Leonsson-Zachrisson
    Clinical and Experimental Nephrology, 2017, 21 : 407 - 416
  • [27] A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers
    Johansson, Susanne
    Rosenbaum, David P.
    Knutsson, Mikael
    Leonsson-Zachrisson, Maria
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (03) : 407 - 416
  • [28] Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers
    Al-Karagholi, Mohammad Al-Mandi
    Hansen, Jakob Moller
    Abou-Kassem, Dalia
    Hansted, Anna Koldbro
    Ubhayasekera, Kumari
    Bergquist, Jonas
    Vecsei, Laszlo
    Jansen-Olesen, Inger
    Ashina, Messoud
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (02):
  • [29] Safety, Tolerability, and Pharmacokinetics of a Novel Oral Phosphodiesterase 4 Inhibitor, ME3183: First-in-Human Phase 1 Study
    Kato, Seiji
    Cho, Naoki
    Koresawa, Tomokazu
    Otake, Kazunari
    Kano, Akiko
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (04): : 341 - 348
  • [30] SYNERGY-1: A Phase 1, First-in-Human, Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics Study of KP104 in Escalating Single and Multiple Doses
    Wabnitz, Paul
    Gao, Xiang
    Ma, Jay
    Tsui, Ping
    Rabe, Martin
    Fu, Helen N.
    He, Chaomei
    Wu, Jingtao
    York, Brian K.
    Weng, Christina
    Rankin, Jon
    Beddingfield, Frederick C.
    Song, Wenru
    Farinola, Nicholas
    Lee, Richard
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 779 - 779
12345